Sign up to get free evidence-based articles, exclusive discounts, and insights from industry-leaders.
Email could not be subscribed.
Thank you for signing up!
presented by Demetra Antimisiaris PharmD, CGP, FASCP
Financial— Demetra Antimisiaris receives compensation from MedBridge for the production of this course. There are no other relevant financial relationships. Nonfinancial— No relevant nonfinancial relationship exists.
Satisfactory completion requirements: All disciplines must complete learning assessments to be awarded credit, no minimum score required unless otherwise specified within the course.
MedBridge is committed to accessibility for all of our subscribers. If you are in need of a disability-related accommodation, please contact [email protected]. We will process requests for reasonable accommodation and will provide reasonable accommodations where appropriate, in a prompt and efficient manner.
Alteration of dosage forms can play a critical role in therapeutic success or failure. What constitutes drug dosage form alteration is often under-recognized. This course provides physical therapists (PTs), occupational therapists (OTs), and Athletic Trainers (ATs) with a primer on the significance of drug dosage form design, FDA dosing recommendations, and the biopharmaceutical implications of altering dosage form or dosing recommendations. We will also discuss real-world practice scenarios regarding the interplay between drug dosage alteration by various stakeholders and the potential impact on outcomes. Dosage form alteration awareness can empower the therapist and AT to detect and assess potential drug dose alterations and their relationship to drug toxicity or treatment failure.
Demetra Antimisiaris PharmD, CGP, FASCP
Demetra Antimisiaris (Dr. Dee) is the director of the University of Louisville's Frazier Polypharmacy and Medication Management Program. This program is dedicated to education, research, and outreach regarding polypharmacy. In addition to teaching Pharmacology to medical and dental students, Dr. Dee provides a weekly polypharmacy clinic and clinical consult service with the U of L…
Read full bioEmail could not be subscribed.
Thank you for signing up!
Thank you!
1. What Is Drug Dosage Form Alteration?
The learner is introduced to the concept of altered drug dosage forms and the potential impact of administration of a the drug under other than recommended conditions. The concepts of FDA drug monographs, prescribing information, and drug administration recommendations will be introduced.
2. Clinical Implications of Dosage Form Design and Altered Drug Dose Administration
In this chapter, a case study will be used to illustrate treatment failures traceable back to altered dosage forms or alteration administration conditions. The topics covered will be a review of therapeutic considerations related to changes in intended dosage forms. Consequences of altered oral dosage forms as well as a review of transdermal patch alterations pitfalls will be included.
3. Implications of Drug Dosage Form Alteration When Working With Therapy Patient and Athletes
This chapter focuses specifically on issues potentially encountered in the therapist and athletic training environment. We will look at administration and dosage form reasons for toxicity or lack of efficacy, and how a patient or athlete’s maintenance medications may impact outcomes should they be altered, not administered correctly, or used under other than normal conditions. The theoretical framework for the section will be a focus on the special situation that activity related to therapy and athletics presents.
More Courses in this Series
Email could not be subscribed.
Thank you for signing up!
Email could not be subscribed.
Thank you for signing up!
For groups of 5 or more, request a demo to learn about our solution and pricing for your organization. For other questions or support, visit our contact page.
Contact sales to learn about our solution and pricing for your organization. For other questions or support, visit our contact page.